Lobe Sciences Ltd.

Recent News

  • Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - July 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Gilberto Jesús Mendoza, President of the World Boxing Association, to its Advisory Board.Philip Young, CEO and Director of Lobe stated, "We are privileged to welcome Gilberto to our Advisory Board and the Lobe family. We all take the maintenance and treatment to improve brain and mental health as a priority. ...

    2021-07-13 8:00 AM EDT
  • Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets

    Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that it became aware of certain promotional activities concerning its common stock on June 10, 2021. Issuer Services at OTC Markets Group (OTC Markets) notified the Company and supplied one (1) electronic newsletter (the "Newsletter") prepared by a third party - HotOtc as an example of such promotion. The Company was not aware of such Newsletter before receiving...

    2021-07-02 5:05 PM EDT
  • Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board

    Investigator, The Lundquist InstituteProfessor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA Vancouver, British Columbia--(Newsfile Corp. - June 28, 2021) -  Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the appointment of Charles Grob, MD Investigator, The Lundquist Institute, and Professor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA, to its Advisory Board.Philip Young, CEO and Director of Lobe stated,...

    2021-06-28 8:45 AM EDT
  • Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

    Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that Philip Young, CEO and Director will be presenting virtually at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference taking place on Thursday, June 17, 2021.H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference Details:Date: Thursday, June 17, 2021Registration & Webcast: https://hcwevents.com/psychedelics/The Company's presentation will be available on-demand at the start of the conference.About...

    2021-06-15 8:45 AM EDT
  • Lobe Sciences to Present at the LD Micro Invitational XI

    Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today that it will be presenting virtually at the LD Micro Invitational XI Conference taking place on Tuesday, June 8th through Thursday, June 10th 2021. Philip Young, CEO and Director will be presenting on Tuesday, June 8th at 5:30 PM ET.Event: Lobe Sciences Presentation at the LD Micro Invitational XIDate: Tuesday, June 8th, 2021 Time: 5:30 PM ETRegister...

    2021-06-07 4:05 PM EDT
  • Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

    Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has entered into a production and supply agreement (the "Agreement") on May 14, 2021 with HAVN Life Sciences Inc. (CSE: HAVN) (OTC Pink: HAVLF) (FSE: 5NP) ("HAVN"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products.Pursuant to the Agreement, HAVN will produce and supply Lobe's...

    2021-05-19 8:45 AM EDT
  • Lobe Sciences to Present at the Benzinga Global Small Cap Conference

    Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. Philip Young, CEO and Director will be presenting on Thursday May 13th at 12:25 pm ET.Philip Young, CEO and Director of Lobe, stated, "We look forward to discussing the latest developments and opportunities ahead of us as we continue...

    2021-05-06 8:30 AM EDT
  • Lobe Sciences Acquires Vitamind Line of Wellness Products

    Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has acquired, through its wholly owned subsidiary Eleusian Biosciences Corp. ("Eleusian"), the consumer goods product line, "Vitamind", pursuant to an asset purchase agreement (the "Purchase Agreement") dated April 30, 2021 between Eleusian and a holding corporation which holds the rights to Vitamind (the "Vendor") (the "Transaction"). Vitamind is a brand of non-psychedelic functional mushroom...

    2021-05-04 8:30 AM EDT